DR. CYNTHIA MAGRO, M.D.
Medical Practice at 68 St, New York, NY

License number
New York 240063
Category
Medical Practice
Type
Specialist
Address
Address
525 E 68Th St, New York, NY 10021
Phone
(646) 253-2808
(212) 746-3856 (Fax)

Personal information

See more information about CYNTHIA MAGRO at radaris.com
Name
Address
Phone
Cynthia Magro, age 60
120 Fort Salonga Rd, Northport, NY 11768
(631) 871-8002
Cynthia Magro, age 66
316 E Main St, Frankfort, NY 13340
Cynthia Magro
44 E 65Th St APT 2B, New York, NY 10065
(614) 406-8015
Cynthia Magro
New York, NY
(646) 678-3989
Cynthia Magro
44 65Th St, Manhattan, NY 10021
(646) 678-3989

Organization information

See more information about CYNTHIA MAGRO at bizstanding.com

Cynthia Magro MD

525 E 68 St, New York, NY 10065

Industry:
Dermatologist
Phone:
(212) 746-6434 (Phone)
Description:
There is 1 doctor at this site. Surgery is not performed at this site.
Cynthia Maria Magro

Professional information

See more information about CYNTHIA MAGRO at trustoria.com
Cynthia Magro Photo 1
Dr. Cynthia Magro, New York NY - MD (Doctor of Medicine)

Dr. Cynthia Magro, New York NY - MD (Doctor of Medicine)

Specialties:
Dermatopathology, Cytopathology
Address:
New York Weill Cornell Medical Center
1300 York Ave SUITE F309, New York 10065
(212) 746-6434 (Phone)
525 E 68Th St, New York 10065
(646) 253-2808 (Phone), (212) 746-3856 (Fax)
Certifications:
Anatomic Pathology, 1988, Cytopathology, 1991, Dermatopathology, 1990
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
New York Weill Cornell Medical Center
1300 York Ave SUITE F309, New York 10065
525 E 68Th St, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
Education:
Medical School
University of Manitoba / Faculty of Medicine
U Manitoba Affil Tchg Hosps
Massachusetts General Hospital


Cynthia Magro Photo 2
Cynthia Magro, New York NY

Cynthia Magro, New York NY

Specialties:
Pathology, Cytopathology, Anatomic Pathology, Dermatopathology, Dermatopathology
Work:
NewYork-Presbyterian / Weill Cornell
525 E 68Th St, New York, NY 10065
Education:
University Of Manitoba Faculty Of Medicine (1984)


Cynthia M Magro Photo 3
Cynthia M Magro, New York NY

Cynthia M Magro, New York NY

Specialties:
Pathologist
Address:
525 E 68Th St, New York, NY 10065


Cynthia Magro Photo 4
Method For Diagnosing Melanocytic Proliferations

Method For Diagnosing Melanocytic Proliferations

US Patent:
2013006, Mar 14, 2013
Filed:
Apr 6, 2011
Appl. No.:
13/642475
Inventors:
Cynthia Magro - New York NY, US
Jonathan Zippin - New York NY, US
Lonny R. Levin - New York NY, US
Jochen Buck - Greenwich CT, US
Assignee:
CORNELL UNIVERSITY - Ithaca NY
International Classification:
G01N 33/574, G01N 33/577
US Classification:
435 74
Abstract:
The invention provides a method for diagnosing a melanocytic proliferation in a subject comprising staining a sample of lesional melanocytes with an antibody against soluble adenylyl cyclase (sAC) and interpreting the sAC staining pattern, which is associated with a diagnosis of a melanocytic proliferation. The sAC staining pattern, which is complex, is discriminatory and distinctive according to the nature of the melanocytic proliferation. The sAC staining pattern comprises one or more of dot-like Golgi staining, broad granular Golgi staining, diffuse cytoplasmic staining, nucleolar staining, incomplete granular nuclear staining, and pan-nuclear staining. The method of the invention is particularly useful in confirming or disaffirming a diagnosis reached through conventional histologic examination of a sample. Additionally, the invention provides a kit for use in interpreting melanocytic proliferations.


Cynthia Magro Photo 5
Methods And Compositions For Treating Degos' Disease

Methods And Compositions For Treating Degos' Disease

US Patent:
2013006, Mar 14, 2013
Filed:
Mar 1, 2011
Appl. No.:
13/582018
Inventors:
Cynthia Magro - New York NY, US
Assignee:
ALEXION PHARMACEUTICALS, INC - CHESHIRE CT
International Classification:
A61K 39/395, A61K 31/343, A61K 31/4439, A61K 31/245, A61P 9/10, A61K 38/17
US Classification:
4241351, 4241721, 4241331, 4241581, 514 209, 514278, 514535, 514469
Abstract:
The present disclosure relates to, inter alia, compositions containing an inhibitor of human complement and/or an inhibitor of interferon alpha, and the use of the compositions in methods for treating or preventing Degos' disease in a subject. In some embodiments, the inhibitor is an antibody, or antigen-binding fragment thereof, that binds to a human complement component C5 protein or to a biologically-active fragment of C5 such as C5a or C5b. In some embodiments, the inhibitor is an antibody, or an antigen-binding fragment thereof, that binds to interferon alpha or to an interferon alpha receptor.